Evidence map›Paper›PMID 33374131›Full record

ArticlePathogens (Basel, Switzerland)2020

Clinical Presentation, Course, and Risk Factors Associated with Mortality in a Severe Outbreak of COVID-19 in Rhode Island, USA, April-June 2020.

Eleftheria Atalla, Raina Zhang, Fadi Shehadeh, Evangelia K Mylona, Maria Tsikala-Vafea, Saisanjana Kalagara, Laura Henseler, Philip A Chan, Eleftherios Mylonakis

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Eleftheria AtallaInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.ORCID 0000-0001-8915-3027
Raina ZhangInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Fadi ShehadehInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Evangelia K MylonaInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Maria Tsikala-VafeaInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Saisanjana KalagaraInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Laura HenselerMedicine and Long-Term Care Associates Llc., Cranston, RI 02920, USA.
Philip A ChanInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Eleftherios MylonakisInfectious Diseases Division, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
Brown University · USRhode Island Department of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term care facilities (LTCFs) have had a disproportionally high mortality rate due to COVID-19. We describe a rapidly escalating COVID-19 outbreak among 116 LTCF residents in Rhode Island, USA. Overall, 111 (95.6%) residents tested positive and, of these, 48 (43.2%) died. The most common comorbidities were hypertension (84.7%) and cardiovascular disease (84.7%). A small percentage (9%) of residents were asymptomatic, while 33.3% of residents were pre-symptomatic, with progression to symptoms within a median of three days following the positive test. While typical symptoms of fever (80.2%) and cough (43.2%) were prevalent, shortness of breath (14.4%) was rarely found despite common hypoxemia (95.5%). The majority of patients demonstrated atypical symptoms with the most common being loss of appetite (61.3%), lethargy (42.3%), diarrhea (37.8%), and fatigue (32.4%). Many residents had increased agitation (38.7%) and anxiety (5.4%), potentially due to the restriction measures or the underlying mental illness. The fever curve was characterized by an intermittent low-grade fever, often the first presenting symptom. Mortality was associated with a disease course beginning with a loss of appetite and lethargy, as well as one more often involving fever greater than 38 °C, loss of appetite, altered mental status, diarrhea, and respiratory distress. Interestingly, no differences in age or comorbidities were noted between survivors and non-survivors. Taking demographic factors into account, treatment with anticoagulation was still associated with reduced mortality (adjusted OR 0.16; 95% C.I. 0.06-0.39;

Indexed as

COVID-19LTCFnursing homespandemic

Identifiers

PMID33374131
PMCPMC7824344
OpenAlexW3116504590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.